Complicated UTI

  • 文章类型: Journal Article
    尿路感染(UTI)是一种众所周知的细菌感染,对儿童造成严重的健康问题。进行了一项回顾性研究,以探讨UTI患儿的尿路病原体及其耐药性。收集尿培养和药敏试验数据。因此,包括840名儿童。总体培养阳性UTI为458(54.52%),大肠杆菌166(36.24%),其次是粪肠球菌59(12.88%),屎肠球菌70(15.28%)等。它们对最常用的抗生素具有高度抗性。在694名患有复杂UTI的儿童中,有8名儿童患有真菌感染。多重耐药(MDR)记录在315(80.98%)中。产超广谱β-内酰胺酶(ESβL)的总比例为25(6.43%)。146名患有简单UTI的儿童,47例(77.05%)也检出MDR。有6例(9.84%)ESβL产生阳性。我们的研究发现,复杂的UTI相对常见。大肠杆菌是最普遍的分离株,其次是屎肠球菌和粪肠球菌。这些生物对最常用的抗生素具有高度抗性。观察到相对较高的MDR患病率和低ESβL产生生物。
    Urinary tract infection (UTI) is a well-known bacterial infection posing serious health problem in children. A retrospective study was conducted to explore the uropathogen and its antibiotic resistance in children with UTI. Data of urine culture and antimicrobial susceptibility test was collected. Consequently, 840 children were included. The overall culture-positive UTI was 458 (54.52 %) with Escherichia coli 166 (36.24 %), followed by Enterococcus faecalis 59 (12.88 %), Enterococcus faecium 70 (15.28 %) and others. They were highly resistant to the most commonly used antibiotics. In 694 children with complicated UTI, there were 8 children with fungal infection. Multiple drug resistance (MDR) was recorded in 315 (80.98 %). The overall proportion of Extended Spectrum β-Lactamase (ESβL) production was 25 (6.43 %). In 146 children with simple UTI, MDR were also detected in 47 (77.05 %). There were 6 (9.84 %) positive for ESβL production. Our study found that complicated UTI was relatively common. Escherichia coli was the most prevalent isolate, followed by Enterococcus faecium and Enterococcus faecalis. These organisms were highly resistant to the most commonly used antibiotics. Relatively high prevalence of MDR and low ESβL-producing organisms were observed.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    Renal abscess is a rare complication of pyelonephritis known to be linked to recurrent urinary tract infections, anatomical abnormalities, obstruction, and the immunocompromised. Symptoms can be very nonspecific such as fever, chills, and abdominal or flank pain, which makes it more challenging to diagnose; however, this has been made easier with the help of medical imaging. Persistently spiking fevers despite antibiotics should prompt a review for possible abscess formation. We describe a case of renal abscess in a previously healthy young female with no risk factors who was successfully treated with antibiotics and radiologically guided percutaneous drainage.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    奈瑟氏球菌粘膜是腐生的人类共生菌,但据报道在易感个体中的一些尿路感染[UTI]中是病原体。在目前的情况下,一个长期存在神经系统问题的年轻女孩,出现膀胱出口梗阻和发烧。她的尿液培养产生了对广谱青霉素敏感的奈瑟氏球菌粘膜,氨基糖苷类,头孢菌素,环丙沙星,和阿奇霉素.她用合适剂量的阿莫西林克拉维酸恢复并出院。由于该女孩过去有各种输尿管和下肢弱点,并且有这种感染的UTI症状,因此此处粘膜的分离变得具有临床意义。
    Neisseria mucosa is saprophytic human commensal but reported as a causative agent in a couple of urinary tract infections [UTI] in susceptible individuals. In the present case, a young girl with long standing neurological problems presented with bladder outlet obstruction and fever. Her urine culture yielded Neisseria mucosa which was susceptible to broad spectrum penicillins, aminoglycosides, cephalosporins, ciprofloxacin, and azithromycin. She recovered with suitable dosage of amoxicillin clavulanic acid and was discharged. Isolation of N. mucosa here becomes clinically significant as this girl had various ureteric and lower limb weaknesses in past and was symptomatic for UTI with this infection.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:美国目前面临关于抗生素抗性细菌的公共卫生危机,和新的尿路感染(UTI)诊断是必要的。患有复发性UTI(rUTI)和复杂UTI(cUTI)的妇女由于其复杂性和缺乏适当的检测方式而处于特别的风险中。标准尿培养(SUC)是诊断的基石,但是它有很多缺点。这些陷阱导致患有rUTI和cUTI的妇女的不满和沮丧,以及过度使用抗生素。一项创新是PCRUTI测试,在有症状的女性中,这已被证明优于SUC。
    目的:本文讨论UTIPCR检测,以及在临床实践中可能的作用。
    方法:对已发表的文献进行综述和总结。
    结果:rUTI和cUTI的管理很复杂,和提供者应提供所有诊断,以促进提供最佳护理。尽管符合保险公司描述的临床适应症参数,但尿液PCR测试仍面临报销问题。
    结论:UTIPCR检测的作用尚不清楚。偿还问题导致使用不足和现实世界结果有限,从而增强了收益。
    结论:本研究提出了一种对rUTI和cUTI女性进行PCR检测的算法。
    BACKGROUND: The United States currently faces a public health crisis with regarding to antibiotic-resistant bacteria, and new urinary tract infection (UTI) diagnostics are needed. Women with recurrent UTI (rUTI) and complicated UTI (cUTI) are at particular risk given their complexity and the paucity of adequate testing modalities. The standard urine culture (SUC) is the cornerstone for diagnosis, but it has many shortcomings. These pitfalls lead to dissatisfaction and frustration among women afflicted with rUTI and cUTI, as well as overuse of antibiotics. One innovation is PCR UTI testing, which has been shown to outperform SUC among symptomatic women.
    OBJECTIVE: This article discusses UTI PCR testing, as well as a possible role in clinical practice.
    METHODS: Published literature was reviewed and summarized.
    RESULTS: Management of rUTI and cUTI is complex, and providers should have all diagnostics available to facilitate providing optimal care. Urine PCR testing faces reimbursement issues despite fulfilling clinical indication parameters as described by insurance companies.
    CONCLUSIONS: The role of UTI PCR testing remains unclear. Reimbursement issues have led to underuse and limited real-world outcomes reinforcing benefit.
    CONCLUSIONS: This study proposes an algorithm for PCR testing among women with rUTI and cUTI.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    磷霉素,仅在美国批准用于膀胱炎,是口服治疗门诊复杂尿路感染(cUTIs)的一种有吸引力的替代方法,因为它对最常见的尿路病原体具有抗菌活性。这项研究是多中心的,随机化,评估口服磷霉素与口服左氧氟沙星策略在cUTIs中的疗效的开放标签实用优势临床试验(FOCUS研究)。该试验比较了在0-48小时肠胃外抗生素治疗后无菌血症的cUTI初始或逐步口服治疗的两种策略。受试者每天分配3g磷霉素或750mg(或根据肾功能调整的剂量)左氧氟沙星,持续5-7天。在治疗结束(EOT)和治愈测试(TOC)(从抗生素开始大约21天)时评估临床和微生物治愈。审判没有达到应计目标;因此,结果是描述性的。只有51名受试者被包括在微生物意向治疗群体中。受试者主要是女性(76%),平均年龄为46.7岁(标准偏差[SD]=20.8)和急性肾盂肾炎(88%)。在治疗结束时,临床治愈保持相似(磷霉素和左氧氟沙星策略的69%和68%,分别),两种策略的微生物成功率均为100%。在治愈的考验中,临床治愈相似(磷霉素和左氧氟沙星策略的84%和86%,分别);然而,观察到磷霉素的微生物成功率较低(69%,左氧氟沙星为84%).这些有限的数据表明,磷霉素可能是一种口服替代品,作为治疗cUTI的降压疗法(登记号NCT03697993)。重要性在目前治疗复杂尿路感染的治疗方案中已经确定了对耐药性和安全性的担忧。磷霉素是一种常规用于治疗单纯性膀胱炎的药物。这项研究表明,磷霉素可以作为一种口服替代药物,作为治疗复杂尿路感染的降压疗法,临床治愈率与左氧氟沙星相当,但从开始使用抗生素后3周的微生物成功率较低。
    OBJECTIVE: Concerns over resistance and safety have been identified in the current treatment regimen for complicated urinary tract infections. Fosfomycin is a drug that is routinely used for the treatment of uncomplicated cystitis. This study shows that fosfomycin could be an oral alternative as step-down therapy for the treatment of complicated urinary tract infections, with a clinical cure rate comparable to levofloxacin but a lower microbiological success rate 3 weeks from start of antibiotics.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    与医院获得性感染相关的肺炎克雷伯菌(Kp)具有广泛耐药性(XDR),使治疗有问题。了解XDR-Kp的遗传流行病学可以通过铁载体的存在确定它们具有高毒力(hv)的潜力。我们对印度医疗机构中14例复杂尿路感染患者中分离出的18种粘菌素抗性XDR-Kp的基因组进行了表征。18种生物包括STs:ST14(9/18),ST147(5/18),ST231(2/18),ST2096(1/18),和ST25(1/18)。一个病房的许多患者感染了相同的ST,这是一个常见的感染源。一些患者反复感染了在该病房中循环的多种STs,为医院传播提供证据。β内酰胺酶基因(blaCTX-M-1,blaSHV,和blaampH)存在于所有分离物中。blaNDM-1存在于分离株15/18中,blaOXA-1存在于分离株16/18中,blaTEM-1D存在于分离株13/18中,blaOXA-48存在于分离株14、19和30中。用各种IS元素破坏mgrB是6个分离株中粘菌素抗性的原因。这些分离株中最常见的K型是K2(10/18)。一个XDR趋同hv-KpST2096与住院时间延长相关(iuc+ybt+blaOXA-1+blaOXA-48)。检测到的聚合XDR-hv-Kp具有爆发潜力,保证有效的抗菌药物管理和感染控制。
    Klebsiella pneumoniae (Kp), which is associated with hospital-acquired infections, is extensively drug-resistant (XDR), making treatment difficult. Understanding the genetic epidemiology of XDR-Kp can help determine its potential to be hypervirulent (hv) through the presence of siderophores. We characterized the genomes of 18 colistin-resistant XDR-Kp isolated from 14 patients with complicated tract infection at an Indian healthcare facility. The 18 organisms comprised the following sequence types (STs): ST14 (n = 9), ST147 (n = 5), ST231 (n = 2), ST2096 (n = 1), and ST25 (n = 1). Many patients in each ward were infected with the same ST, suggesting a common source of infection. Some patients had recurrent infections with multiple STs circulating in the ward, providing evidence of hospital transmission. β-lactamase genes (blaCTX-M-1, blaSHV, and blaampH) were present in all isolates. blaNDM-1 was present in 15 isolates, blaOXA-1 in 16 isolates, blaTEM-1D in 13 isolates, and blaOXA-48 in 3 isolates. Disruption of mgrB by various insertion sequences was responsible for colistin resistance in 6 isolates. The most common K-type among isolates was K2 (n = 10). One XDR convergent hvKp ST2096 mutation (iuc+ybt+blaOXA-1+blaOXA-48) was associated with prolonged hospitalization. Convergent XDR-hvKp has outbreak potential, warranting effective antimicrobial stewardship and infection control.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    高氨血症性脑病(HE)可以广泛定义为由于血氨水平升高而引起的意识水平的改变。虽然肝硬化是HE的最常见原因,非肝原因如药物,感染,和波尔图系统分流也可以导致演示。在这种情况下,我们强调了一名老年男性患者因尿路梗阻感染(UTI)合并尿素分解微生物引起的复发性非肝硬化性HE的异常发生.患者表现出精神改变,和氨水平升高,肝功能正常。尿液培养显示奇异变形杆菌对超广谱β-内酰胺酶(ESBL)具有抗性。通过Foley的导管插入术和静脉(IV)抗生素成功治疗阻塞性UTI,导致了他的决议。该结果进一步支持UTI作为高氨血症的潜在原因的重要性。因此,UTI作为高氨血症的非肝脏原因之一,应始终在出现状态改变的老年患者中进行探索。
    Hyperammonemic encephalopathy (HE) can be broadly defined as an alteration in the level of consciousness due to elevated blood ammonia level. While hepatic cirrhosis is the most common cause of HE, non-hepatic causes like drugs, infections, and porto-systemic shunts can also lead to the presentation. In this case, we highlight an unusual occurrence of recurrent non-cirrhotic HE from obstructive urinary tract infection (UTI) with urea-splitting micro-organisms in an elderly male patient. The patient exhibited altered mentation, and elevated ammonia levels with normal hepatic function at presentation. Urine culture revealed Proteus mirabilis resistant to extended spectrum beta-lactamases (ESBL). Successful management of obstructive UTI was achieved through Foley\'s catheterization and intravenous (IV) antibiotics, resulting in the resolution of HE. This outcome further supports the significance of UTI as a potential cause of hyperammonemia. Thus, UTI as one of the non-hepatic causes of hyperammonemia should always be explored among elderly patients presenting with altered mentation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    未经证实:复杂UTI(cUTI)在脊髓损伤和疾病(SCI/D)患者中非常普遍,但既不存在一致也不存在循证指南。
    UNASSIGNED:我们建议分为两个阶段,混合方法研究,以在SCI/D患者和治疗它们的临床医生之间就cUTI的诊断和决策标准达成共识。
    未经评估:在第一阶段(定性),我们将聘请脊髓损伤模型系统(SCIMS)的临床医生在焦点小组中使用三个可靠且经过验证的神经源性膀胱的泌尿系统症状问卷(USQNBs;间歇性导管插入,留置导尿管,和作废)作为出发点,然后我们将进行Delphi调查,以探索并在全国代表性的物理医学和康复临床医生样本中就cUTI诊断标准达成共识,传染病,泌尿科,初级保健,和急诊医学。我们将根据这些新指南开发培训材料,并将培训部署到全国的临床医生和消费者。在第二阶段(定量),我们将评估临床医生对指南的吸收和使用,以及指南培训对消费者自我管理习惯的影响,参与医疗保健系统,培训后12个月内使用抗生素。
    UNASSIGNED:这项研究的结果将是因SCI/D而患有神经源性下尿路功能障碍(NLUTD)的人群中cUTI的诊断指南,与摄取(临床医生)和影响(患者)的数据。
    UNASSIGNED:该混合方法协议将正式的心理测量方法与大规模证据收集相结合,以在因SCI/D引起的NULTD患者中就cUTI的诊断指南达成共识,并提供有关摄取(临床医生)和影响(患者)的信息。
    UNASSIGNED: Complicated UTI (cUTI) is highly prevalent among people with spinal cord injury and disease (SCI/D), but neither consistent nor evidence-based guidelines exist.
    UNASSIGNED: We propose a two-phase, mixed-methods study to develop consensus around diagnostic and decision-making criteria for cUTI among people with SCI/D and the clinicians who treat them.
    UNASSIGNED: In phase 1 (qualitative), we will engage Spinal Cord Injury Model Systems (SCIMS) clinicians in focus groups to refine existing cUTI-related decision making using three reliable and validated Urinary Symptom Questionnaires for Neurogenic Bladder (USQNBs; intermittent catheterization, indwelling catheterization, and voiding) as points of departure, and then we will conduct a Delphi survey to explore and achieve consensus on cUTI diagnostic criteria among a nationally representative sample of clinicians from physical medicine and rehabilitation, infectious disease, urology, primary care, and emergency medicine. We will develop training materials based on these new guidelines and will deploy the training to both clinicians and consumers nationally. In phase 2 (quantitative), we will assess clinicians\' uptake and use of the guidelines, and the impact of the guidelines training on consumers\' self-management habits, engagement with the health care system, and antibiotic use over the 12 months after training.
    UNASSIGNED: The output of this study will be diagnostic guidelines for cUTI among people with neurogenic lower urinary tract dysfunction (NLUTD) due to SCI/D, with data on uptake (clinicians) and impact (patients).
    UNASSIGNED: This mixed-methods protocol integrates formal psychometric methods with large-scale evidence gathering to derive consensus around diagnostic guidelines for cUTI among people with NLUTD due to SCI/D and provides information on uptake (clinicians) and impact (patients).
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    气肿性膀胱炎(EC)是一种潜在的危及生命的尿路感染(UTI),其特征是膀胱壁和管腔内存在气体。气体超出膀胱壁的延伸是罕见的,表明严重的疾病。我们介绍了一例继发于EC的败血性休克,空气通过椎旁和腰大肌并进入腰椎管的硬膜外腔。脊柱内空气的这种发现是一种罕见的影像学现象,称为肺出血(PR)。
    Emphysematous cystitis (EC) is a potentially life-threatening urinary tract infection (UTI) characterized by the presence of gas within the bladder wall and lumen. The extension of gas beyond the bladder wall is rare and indicative of severe disease. We present a case of septic shock secondary to EC with the extension of air through the paraspinal and psoas muscles and into the epidural space of the lumbar spinal canal. This finding of intraspinal air is a rare radiographic phenomenon known as pneumorrhachis (PR).
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    未经评估:在美国,每年有>100万急诊就诊和100,000例尿路感染(UTI)入院。UTI总体积的一小部分,复杂(cUTI)每年给医疗保健系统带来超过35亿美元的成本。我们用cUTI评估了急诊室(ED)就诊的当代年度负担。
    UNASSIGNED:我们在国家急诊室数据库中进行了一项横断面多中心研究,所有美国医院ED的20%分层抽样,2016-2018年,探索具有cUTI的访问特征。我们比较了cUTI作为主要诊断(PD)和次要诊断(非PD)。我们应用调查方法来制定国家估计。
    未经批准:在2,379,448例EDcUTI访问(44.8%PD)中,40.1%为女性(45.1%PD;36.9%非PD),62.2%≥65岁(52.5%PD;70.2%非PD)。平均Charlson评分为2.3(3.0PD;2.1非PD);终末期肾病患病率为2.3%(1.4%PD;3.0%非PD)。而肾盂肾炎发生在两组的10%,严重脓毒症(7.2%vs2.0%)和脓毒性休克(7.1%vs1.8%)在cUTI-non-PD患者中的发病率是cUTI-PD的4倍.总的来说,所有访视的三分之二以住院结束(44.9%PD;85.5%非PD).尽管访问次数相似,cUTI的年度全国ED账单从2016年的28亿美元上升到2018年的32亿美元。
    未经评估:在2016-2018年,cUTI有超过200万次ED访问。尽管<10%符合严重脓毒症/脓毒性休克的标准,三分之二被录取。cUTI访问的总成本上升了15%,但数量没有大幅增加。
    UNASSIGNED: There are >1 million emergency department visits and 100,000 admissions with urinary tract infection (UTI) annually in the United States. A fraction of total UTI volume, complicated (cUTI) costs the health care system over $3.5 billion per year. We evaluated the contemporary annual burden of emergency department (ED) visits with cUTI.
    UNASSIGNED: We conducted a cross-sectional multicenter study within the National Emergency Department database, a 20% stratified sample of all US hospital-based EDs, 2016-2018, to explore characteristics of visits with a cUTI. We compared cUTI as the principal (PD) versus secondary diagnosis (non-PD). We applied survey methods to develop national estimates.
    UNASSIGNED: Among 2,379,448 ED cUTI visits (44.8% PD), 40.1% were female (45.1% PD; 36.9% non-PD) and 62.2% were ≥ 65 years (52.5% PD; 70.2% non-PD). Mean Charlson score was 2.3 (3.0 PD; 2.1 non-PD); end-stage renal disease prevalence was 2.3% (1.4% PD; 3.0% non-PD). Whereas pyelonephritis occurred in ∼10% of both groups, severe sepsis (7.2% vs 2.0%) and septic shock (7.1% vs 1.8%) were ∼4 times more prevalent among those with cUTI-non-PD than cUTI-PD. Overall, two thirds of all visits ended in hospitalization (44.9% PD; 85.5% non-PD). Despite similar numbers of visits, the annual national ED bill for cUTI rose from $2.8 billion in 2016 to $3.2 billion in 2018.
    UNASSIGNED: There were over 2 million ED visits with cUTI in 2016-2018. Although <10% met criteria for severe sepsis/septic shock, ∼two thirds were admitted. The aggregate cost for cUTI visits rose by 15% without a substantial increase in volume.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号